Epidemiological and clinical analysis of pemphigoid patients in northeastern Poland in 2000-2005

Medical Science Monitor

Volumn 13, Issue 8, 2007, Pages

  Serwin, Agnieszka Beata ^a   Bokiniec, Ewa ^a   Piascik, Marta ^a   Masny, Dominik ^a   Chodynicka, Bozena ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Concomitant diseases; Incidence; Pemphigoid

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; INSULIN; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SIMVASTATIN; SPIRONOLACTONE; THYRONINE; TRIPTORELIN;

AGED; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INFECTION; MALE; MORBIDITY; MORTALITY; NEOPLASM; OSTEOPOROSIS; PEMPHIGOID; POLAND; PREVALENCE; RURAL AREA; SERODIAGNOSIS; SKIN DEFECT; STOMACH HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIGENS; AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; DERMATOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; POLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548398125     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. th ed. Oxford: Blackwell Science, 2005
2. Bastuji-Garin S, Joly P, Picard-Dahan C et al: Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol, 1996; 132: 172-76
3. Modeste A-B, Cordel N, Courville Ph et al: Bullous pemphigoid induced by spironolactone. Ann Dermatol Venereol, 2002; 129: 56-58
4. Baz K, Ikizoglu G, Kaya TI, Koca A: Fuosemide-induced bullous pemphigoid. JEADV, 2002; 16: 81-82
5. Perry A, Sparling JD, Pennington M: Bullous pemphigoid following therapy with an oral beta-blocker. J Drugs Dermatol, 2005; 4: 746-48
6. Kayashima K, Koji T, Nozawa M et al: Activation of bullous pemphigoid antigen gene in mouse ear epidermis by ultraviolet radiation. Cell Biochem Funct, 1998; 6: 107-16
7. Thomson K, Schmidt H: PUVA-induced bullous pemphigoid. Br J Dermatol, 1976; 95: 568-69
8. Lee CW, Ro YS: Sun-induced localized bullous pemphigoid. Br J Dermatol, 1992; 126: 91-92
9. Folliero G, Zurlo A, Amanti C et al: Bullous pemphigoid induced by radiation therapy. Clin Oncol, 1995; 7: 266-67
10. Wojnarowska F, Kirtschig G, Highet AS et al: Guidelines for the management of bullous pemphigoid. Br J Dermatol, 2002; 147: 214-21
11. Roujeau J-C, Lok C, Bastuji-Garin S et al: High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol, 1998; 134: 465-69
12. Bernard P, Bedane C, Monnetblanc J-M: Anti-BP 180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients. Br J Dermatol, 1997; 136: 694-98
13. Muramatsu T, Iida T, Tada H et al: Bullous pemphigoid associated with internal malignancies: identification of 180-kDa antigen by Western immunoblotting. Br J Dermatol, 1996; 135: 782-84
14. Ogawa H, Sakuma M, Morioka S et al: The incidence of internal malignances in pemphigus and bullous pemphigoid in Japan. J Dermatol Sci, 1995; 9: 136-41
15. Venning VA, Wojnarowska F: The association of bullous pemphigoid and malignant disease: a case control study. Br J Dermatol, 1990; 123: 439-45
16. DeHoratius DM, Sperber BR, Werth VP: Glucocorticosteroids in the treatment of bullous diseases. Dermatol Therapy, 2002; 15: 298-310
17. Central Statistical Office: Statistical yearbook of agriculture and rural areas. Warsaw, The Office, 2005
18. Gudi VS, White MI, Cruickshank N et al: Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland. Br J Dermatol, 2005; 153: 424-27
19. Bernard P, Saillant L, Labeille B et al: Incidence and distribution of subepidermal autoimmune bullous diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol, 1995; 131: 48-52
20. Zilikens D, Wever S, Roth A, Bröcker E-B: Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol, 1995; 131: 957-58
21. Stroebner P-E, Michot C, Ligeron C et al: Simvastatin-induced lichen planus pemphigoides. Ann Dermatol Venereol, 2003; 130: 187-90